Serveur d'exploration sur la COVID en France

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

[Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review].

Identifieur interne : 000180 ( Main/Exploration ); précédent : 000179; suivant : 000181

[Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review].

Auteurs : A. Chevance [France] ; D. Gourion [France] ; N. Hoertel [France] ; P-M Llorca [France] ; P. Thomas [France] ; R. Bocher [France] ; M-R Moro [France] ; V. Laprévote [France] ; A. Benyamina [France] ; P. Fossati [France] ; M. Masson [France] ; E. Leaune [France] ; M. Leboyer [France] ; R. Gaillard [France]

Source :

RBID : pubmed:32312567

Descripteurs français

English descriptors

Abstract

OBJECTIVE

The lack of ressources and coordination to face the epidemic of coronavirus raises concerns for the health of patients with mental disorders in a country where we keep in memory the dramatic experience of famine in psychiatric hospitals during the Second World War. This article aims at proposing guidance to ensure mental health care during the SARS-CoV epidemy in France.

METHODS

Authors performed a narrative review identifying relevant results in the scientific and medical literature and local initiatives in France.

RESULTS

We identified four types of major vulnerabilities in patients suffering from mental disorders during this pandemic: (1) medical comorbidities that are more frequently found in patients suffering from mental disorders (cardiovascular and pulmonary pathologies, diabetes, obesity, etc.) which represent risk factors for severe infections with Covid-19; (2) age (the elderly constituting the population most vulnerable to coronavirus); (3) cognitive and behavioral troubles which can hamper compliance with confinement and hygiene measures and finally and (4) psychosocial vulnerability due to stigmatization and/or socio-economic difficulties. Furthermore, the mental health healthcare system is more vulnerable than other healthcare systems. Current government plans are poorly adapted to psychiatric establishments in a context of major shortage of organizational, material and human resources. In addition, a certain number of structural aspects make the psychiatric institution particularly vulnerable: many beds are closed, wards have a high density of patients, mental health community facilities are closed, medical teams are understaffed and poorly trained to face infectious diseases. We could also face major issues in referring patients with acute mental disorders to intensive care units. To maintain continuity of psychiatric care in this pandemic situation, several directions can be considered, in particular with the creation of Covid+ units. These units are under the dual supervision of a psychiatrist and of an internist/infectious disease specialist; all new entrants should be placed in quarantine for 14 days; the nurse staff should benefit from specific training, from daily medical check-ups and from close psychological support. Family visits would be prohibited and replaced by videoconference. At the end of hospitalization, in particular for the population of patients in compulsory ambulatory care situations, specific case-management should be organized with the possibility of home visits, in order to support them when they get back home and to help them to cope with the experience of confinement, which is at risk to induce recurrences of mental disorders. The total or partial closure of mental health community facilities is particularly disturbing for patients but a regular follow-up is possible with telemedicine and should include the monitoring of the suicide risk and psychoeducation strategies; developing support platforms could also be very helpful in this context. Private psychiatrists have also a crucial role of information with their patients on confinement and barrier measures, but also on measures to prevent the psychological risks inherent to confinement: maintenance of sleep regularity, physical exercise, social interactions, stress management and coping strategies, prevention of addictions, etc. They should also be trained to prevent, detect and treat early warning symptoms of post-traumatic stress disorder, because their prevalence was high in the regions of China most affected by the pandemic.

DISCUSSION

French mental healthcare is now in a great and urgent need for reorganization and must also prepare in the coming days and weeks to face an epidemic of emotional disorders due to the containment of the general population.


DOI: 10.1016/j.encep.2020.03.001
PubMed: 32312567
PubMed Central: PMC7130411


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">[Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review].</title>
<author>
<name sortKey="Chevance, A" sort="Chevance, A" uniqKey="Chevance A" first="A" last="Chevance">A. Chevance</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université de Paris, CRESS, Inserm, INRA, 75004 Paris, France. Electronic address: astrid.chevance@gmail.com.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Paris, CRESS, Inserm, INRA, 75004 Paris</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gourion, D" sort="Gourion, D" uniqKey="Gourion D" first="D" last="Gourion">D. Gourion</name>
<affiliation wicri:level="3">
<nlm:affiliation>HEC Paris (Jouy-en-Josas), Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>HEC Paris (Jouy-en-Josas), Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hoertel, N" sort="Hoertel, N" uniqKey="Hoertel N" first="N" last="Hoertel">N. Hoertel</name>
<affiliation wicri:level="3">
<nlm:affiliation>Centre ressource régional de psychiatrie du sujet âgé (CRRPSA), service de psychiatrie et d'addictologie de l'adulte et du sujet âgé, DMU psychiatrie et addictologie, Inserm U1266, institut de psychiatrie et neurosciences de Paris, centre université de Paris, AP-HP, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre ressource régional de psychiatrie du sujet âgé (CRRPSA), service de psychiatrie et d'addictologie de l'adulte et du sujet âgé, DMU psychiatrie et addictologie, Inserm U1266, institut de psychiatrie et neurosciences de Paris, centre université de Paris, AP-HP, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Llorca, P M" sort="Llorca, P M" uniqKey="Llorca P" first="P-M" last="Llorca">P-M Llorca</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université Clermont-Auvergne, CHU de Clermont-Ferrand, Clermont-Ferrand, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Clermont-Auvergne, CHU de Clermont-Ferrand, Clermont-Ferrand</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Auvergne (région administrative)</region>
<settlement type="city">Clermont-Ferrand</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Thomas, P" sort="Thomas, P" uniqKey="Thomas P" first="P" last="Thomas">P. Thomas</name>
<affiliation wicri:level="3">
<nlm:affiliation>Laboratoire de sciences cognitives et sciences affectives (SCALab-PsyCHIC), université de Lille, CNRS UMR 9193, CHU de Lille, Lille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de sciences cognitives et sciences affectives (SCALab-PsyCHIC), université de Lille, CNRS UMR 9193, CHU de Lille, Lille</wicri:regionArea>
<placeName>
<region type="region">Hauts-de-France</region>
<region type="old region">Nord-Pas-de-Calais</region>
<settlement type="city">Lille</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bocher, R" sort="Bocher, R" uniqKey="Bocher R" first="R" last="Bocher">R. Bocher</name>
<affiliation wicri:level="3">
<nlm:affiliation>CHU de Nantes, Nantes, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>CHU de Nantes, Nantes</wicri:regionArea>
<placeName>
<region type="region">Pays de la Loire</region>
<region type="old region">Pays de la Loire</region>
<settlement type="city">Nantes</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Moro, M R" sort="Moro, M R" uniqKey="Moro M" first="M-R" last="Moro">M-R Moro</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université de Paris, collège national des universitaires de psychiatrie (CNUP), Inserm, CESP, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Paris, collège national des universitaires de psychiatrie (CNUP), Inserm, CESP, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Laprevote, V" sort="Laprevote, V" uniqKey="Laprevote V" first="V" last="Laprévote">V. Laprévote</name>
<affiliation wicri:level="3">
<nlm:affiliation>Pôle hospitalo-universitaire de psychiatrie d'adultes et d'addictologie du Grand-Nancy, centre psychothérapique de Nancy, Laxou, France; Faculté de médecine, université de Lorraine, Nancy, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Pôle hospitalo-universitaire de psychiatrie d'adultes et d'addictologie du Grand-Nancy, centre psychothérapique de Nancy, Laxou, France; Faculté de médecine, université de Lorraine, Nancy</wicri:regionArea>
<placeName>
<region type="region">Grand Est</region>
<region type="old region">Lorraine (région)</region>
<settlement type="city">Nancy</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Benyamina, A" sort="Benyamina, A" uniqKey="Benyamina A" first="A" last="Benyamina">A. Benyamina</name>
<affiliation wicri:level="3">
<nlm:affiliation>Département de psychiatrie et d'addictologie, hôpital Paul-Brousse, AP-HP, 94800 Villejuif, France; Unité psychiatrie-comorbidités-addictions-unité de recherche, PSYCOMADD université Paris Sud, université Paris Saclay, AP-HP, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Département de psychiatrie et d'addictologie, hôpital Paul-Brousse, AP-HP, 94800 Villejuif, France; Unité psychiatrie-comorbidités-addictions-unité de recherche, PSYCOMADD université Paris Sud, université Paris Saclay, AP-HP, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Fossati, P" sort="Fossati, P" uniqKey="Fossati P" first="P" last="Fossati">P. Fossati</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service de psychiatrie adultes, Sorbonne université, groupe hospitalier Pitié-Salpêtrière, ICM, Inserm U1127, AP-HP, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de psychiatrie adultes, Sorbonne université, groupe hospitalier Pitié-Salpêtrière, ICM, Inserm U1127, AP-HP, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Masson, M" sort="Masson, M" uniqKey="Masson M" first="M" last="Masson">M. Masson</name>
<affiliation wicri:level="3">
<nlm:affiliation>SHU, GHU psychiatrie et neurosciences, Nightingale Hospitals-Paris, clinique du Château-de-Garches, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>SHU, GHU psychiatrie et neurosciences, Nightingale Hospitals-Paris, clinique du Château-de-Garches, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Leaune, E" sort="Leaune, E" uniqKey="Leaune E" first="E" last="Leaune">E. Leaune</name>
<affiliation wicri:level="3">
<nlm:affiliation>Centre hospitalier Le Vinatier, Bron, France; Université Lyon, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre hospitalier Le Vinatier, Bron, France; Université Lyon, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Leboyer, M" sort="Leboyer, M" uniqKey="Leboyer M" first="M" last="Leboyer">M. Leboyer</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université Paris Est Créteil, Inserm, Fondation FondaMental, AP-HP, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris Est Créteil, Inserm, Fondation FondaMental, AP-HP, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gaillard, R" sort="Gaillard, R" uniqKey="Gaillard R" first="R" last="Gaillard">R. Gaillard</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université de Paris, GHU psychiatrie et neurosciences, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Paris, GHU psychiatrie et neurosciences, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32312567</idno>
<idno type="pmid">32312567</idno>
<idno type="doi">10.1016/j.encep.2020.03.001</idno>
<idno type="pmc">PMC7130411</idno>
<idno type="wicri:Area/Main/Corpus">001658</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001658</idno>
<idno type="wicri:Area/Main/Curation">001658</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001658</idno>
<idno type="wicri:Area/Main/Exploration">001658</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">[Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review].</title>
<author>
<name sortKey="Chevance, A" sort="Chevance, A" uniqKey="Chevance A" first="A" last="Chevance">A. Chevance</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université de Paris, CRESS, Inserm, INRA, 75004 Paris, France. Electronic address: astrid.chevance@gmail.com.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Paris, CRESS, Inserm, INRA, 75004 Paris</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gourion, D" sort="Gourion, D" uniqKey="Gourion D" first="D" last="Gourion">D. Gourion</name>
<affiliation wicri:level="3">
<nlm:affiliation>HEC Paris (Jouy-en-Josas), Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>HEC Paris (Jouy-en-Josas), Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hoertel, N" sort="Hoertel, N" uniqKey="Hoertel N" first="N" last="Hoertel">N. Hoertel</name>
<affiliation wicri:level="3">
<nlm:affiliation>Centre ressource régional de psychiatrie du sujet âgé (CRRPSA), service de psychiatrie et d'addictologie de l'adulte et du sujet âgé, DMU psychiatrie et addictologie, Inserm U1266, institut de psychiatrie et neurosciences de Paris, centre université de Paris, AP-HP, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre ressource régional de psychiatrie du sujet âgé (CRRPSA), service de psychiatrie et d'addictologie de l'adulte et du sujet âgé, DMU psychiatrie et addictologie, Inserm U1266, institut de psychiatrie et neurosciences de Paris, centre université de Paris, AP-HP, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Llorca, P M" sort="Llorca, P M" uniqKey="Llorca P" first="P-M" last="Llorca">P-M Llorca</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université Clermont-Auvergne, CHU de Clermont-Ferrand, Clermont-Ferrand, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Clermont-Auvergne, CHU de Clermont-Ferrand, Clermont-Ferrand</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Auvergne (région administrative)</region>
<settlement type="city">Clermont-Ferrand</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Thomas, P" sort="Thomas, P" uniqKey="Thomas P" first="P" last="Thomas">P. Thomas</name>
<affiliation wicri:level="3">
<nlm:affiliation>Laboratoire de sciences cognitives et sciences affectives (SCALab-PsyCHIC), université de Lille, CNRS UMR 9193, CHU de Lille, Lille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de sciences cognitives et sciences affectives (SCALab-PsyCHIC), université de Lille, CNRS UMR 9193, CHU de Lille, Lille</wicri:regionArea>
<placeName>
<region type="region">Hauts-de-France</region>
<region type="old region">Nord-Pas-de-Calais</region>
<settlement type="city">Lille</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bocher, R" sort="Bocher, R" uniqKey="Bocher R" first="R" last="Bocher">R. Bocher</name>
<affiliation wicri:level="3">
<nlm:affiliation>CHU de Nantes, Nantes, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>CHU de Nantes, Nantes</wicri:regionArea>
<placeName>
<region type="region">Pays de la Loire</region>
<region type="old region">Pays de la Loire</region>
<settlement type="city">Nantes</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Moro, M R" sort="Moro, M R" uniqKey="Moro M" first="M-R" last="Moro">M-R Moro</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université de Paris, collège national des universitaires de psychiatrie (CNUP), Inserm, CESP, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Paris, collège national des universitaires de psychiatrie (CNUP), Inserm, CESP, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Laprevote, V" sort="Laprevote, V" uniqKey="Laprevote V" first="V" last="Laprévote">V. Laprévote</name>
<affiliation wicri:level="3">
<nlm:affiliation>Pôle hospitalo-universitaire de psychiatrie d'adultes et d'addictologie du Grand-Nancy, centre psychothérapique de Nancy, Laxou, France; Faculté de médecine, université de Lorraine, Nancy, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Pôle hospitalo-universitaire de psychiatrie d'adultes et d'addictologie du Grand-Nancy, centre psychothérapique de Nancy, Laxou, France; Faculté de médecine, université de Lorraine, Nancy</wicri:regionArea>
<placeName>
<region type="region">Grand Est</region>
<region type="old region">Lorraine (région)</region>
<settlement type="city">Nancy</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Benyamina, A" sort="Benyamina, A" uniqKey="Benyamina A" first="A" last="Benyamina">A. Benyamina</name>
<affiliation wicri:level="3">
<nlm:affiliation>Département de psychiatrie et d'addictologie, hôpital Paul-Brousse, AP-HP, 94800 Villejuif, France; Unité psychiatrie-comorbidités-addictions-unité de recherche, PSYCOMADD université Paris Sud, université Paris Saclay, AP-HP, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Département de psychiatrie et d'addictologie, hôpital Paul-Brousse, AP-HP, 94800 Villejuif, France; Unité psychiatrie-comorbidités-addictions-unité de recherche, PSYCOMADD université Paris Sud, université Paris Saclay, AP-HP, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Fossati, P" sort="Fossati, P" uniqKey="Fossati P" first="P" last="Fossati">P. Fossati</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service de psychiatrie adultes, Sorbonne université, groupe hospitalier Pitié-Salpêtrière, ICM, Inserm U1127, AP-HP, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de psychiatrie adultes, Sorbonne université, groupe hospitalier Pitié-Salpêtrière, ICM, Inserm U1127, AP-HP, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Masson, M" sort="Masson, M" uniqKey="Masson M" first="M" last="Masson">M. Masson</name>
<affiliation wicri:level="3">
<nlm:affiliation>SHU, GHU psychiatrie et neurosciences, Nightingale Hospitals-Paris, clinique du Château-de-Garches, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>SHU, GHU psychiatrie et neurosciences, Nightingale Hospitals-Paris, clinique du Château-de-Garches, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Leaune, E" sort="Leaune, E" uniqKey="Leaune E" first="E" last="Leaune">E. Leaune</name>
<affiliation wicri:level="3">
<nlm:affiliation>Centre hospitalier Le Vinatier, Bron, France; Université Lyon, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre hospitalier Le Vinatier, Bron, France; Université Lyon, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Leboyer, M" sort="Leboyer, M" uniqKey="Leboyer M" first="M" last="Leboyer">M. Leboyer</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université Paris Est Créteil, Inserm, Fondation FondaMental, AP-HP, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris Est Créteil, Inserm, Fondation FondaMental, AP-HP, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gaillard, R" sort="Gaillard, R" uniqKey="Gaillard R" first="R" last="Gaillard">R. Gaillard</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université de Paris, GHU psychiatrie et neurosciences, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Paris, GHU psychiatrie et neurosciences, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">L'Encephale</title>
<idno type="ISSN">0013-7006</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aftercare (MeSH)</term>
<term>Age Factors (MeSH)</term>
<term>Aged, 80 and over (MeSH)</term>
<term>Antiviral Agents (pharmacokinetics)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Child (MeSH)</term>
<term>Cognition Disorders (epidemiology)</term>
<term>Cognition Disorders (therapy)</term>
<term>Comorbidity (MeSH)</term>
<term>Continuity of Patient Care (organization & administration)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (psychology)</term>
<term>Drug Interactions (MeSH)</term>
<term>France (epidemiology)</term>
<term>Hospital Units (organization & administration)</term>
<term>Hospitals, Psychiatric (organization & administration)</term>
<term>Humans (MeSH)</term>
<term>Infection Control (methods)</term>
<term>Mental Disorders (epidemiology)</term>
<term>Mental Disorders (etiology)</term>
<term>Mental Disorders (therapy)</term>
<term>Mental Health Services (organization & administration)</term>
<term>Mental Health Services (supply & distribution)</term>
<term>Pandemics (MeSH)</term>
<term>Patient Care Team (MeSH)</term>
<term>Patient Compliance (MeSH)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (psychology)</term>
<term>Prisoners (psychology)</term>
<term>Stress Disorders, Post-Traumatic (etiology)</term>
<term>Stress Disorders, Post-Traumatic (therapy)</term>
<term>Stress, Psychological (etiology)</term>
<term>Stress, Psychological (therapy)</term>
<term>Substance-Related Disorders (epidemiology)</term>
<term>Substance-Related Disorders (therapy)</term>
<term>Suicide (prevention & control)</term>
<term>Vulnerable Populations (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Antiviraux (pharmacocinétique)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Comorbidité (MeSH)</term>
<term>Continuité des soins (organisation et administration)</term>
<term>Enfant (MeSH)</term>
<term>Facteurs âges (MeSH)</term>
<term>France (épidémiologie)</term>
<term>Humains (MeSH)</term>
<term>Hôpitaux psychiatriques (organisation et administration)</term>
<term>Infections à coronavirus (psychologie)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Interactions médicamenteuses (MeSH)</term>
<term>Observance par le patient (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (psychologie)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Populations vulnérables (MeSH)</term>
<term>Post-cure (MeSH)</term>
<term>Prisonniers (psychologie)</term>
<term>Prévention des infections (méthodes)</term>
<term>Services de santé mentale (organisation et administration)</term>
<term>Services de santé mentale (ressources et distribution)</term>
<term>Stress psychologique (thérapie)</term>
<term>Stress psychologique (étiologie)</term>
<term>Suicide (prévention et contrôle)</term>
<term>Sujet âgé de 80 ans ou plus (MeSH)</term>
<term>Troubles de la cognition (thérapie)</term>
<term>Troubles de la cognition (épidémiologie)</term>
<term>Troubles de stress post-traumatique (thérapie)</term>
<term>Troubles de stress post-traumatique (étiologie)</term>
<term>Troubles liés à une substance (thérapie)</term>
<term>Troubles liés à une substance (épidémiologie)</term>
<term>Troubles mentaux (thérapie)</term>
<term>Troubles mentaux (épidémiologie)</term>
<term>Troubles mentaux (étiologie)</term>
<term>Unités hospitalières (organisation et administration)</term>
<term>Équipe soignante (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en">
<term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>France</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Cognition Disorders</term>
<term>Coronavirus Infections</term>
<term>Mental Disorders</term>
<term>Pneumonia, Viral</term>
<term>Substance-Related Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Mental Disorders</term>
<term>Stress Disorders, Post-Traumatic</term>
<term>Stress, Psychological</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Infection Control</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr">
<term>Prévention des infections</term>
</keywords>
<keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr">
<term>Continuité des soins</term>
<term>Hôpitaux psychiatriques</term>
<term>Services de santé mentale</term>
<term>Unités hospitalières</term>
</keywords>
<keywords scheme="MESH" qualifier="organization & administration" xml:lang="en">
<term>Continuity of Patient Care</term>
<term>Hospital Units</term>
<term>Hospitals, Psychiatric</term>
<term>Mental Health Services</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacocinétique" xml:lang="fr">
<term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Suicide</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr">
<term>Suicide</term>
</keywords>
<keywords scheme="MESH" qualifier="psychologie" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Prisonniers</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Prisoners</term>
</keywords>
<keywords scheme="MESH" qualifier="ressources et distribution" xml:lang="fr">
<term>Services de santé mentale</term>
</keywords>
<keywords scheme="MESH" qualifier="supply & distribution" xml:lang="en">
<term>Mental Health Services</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Cognition Disorders</term>
<term>Mental Disorders</term>
<term>Stress Disorders, Post-Traumatic</term>
<term>Stress, Psychological</term>
<term>Substance-Related Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr">
<term>Stress psychologique</term>
<term>Troubles de la cognition</term>
<term>Troubles de stress post-traumatique</term>
<term>Troubles liés à une substance</term>
<term>Troubles mentaux</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>France</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Troubles de la cognition</term>
<term>Troubles liés à une substance</term>
<term>Troubles mentaux</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Stress psychologique</term>
<term>Troubles de stress post-traumatique</term>
<term>Troubles mentaux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aftercare</term>
<term>Age Factors</term>
<term>Aged, 80 and over</term>
<term>Betacoronavirus</term>
<term>Child</term>
<term>Comorbidity</term>
<term>Drug Interactions</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Patient Care Team</term>
<term>Patient Compliance</term>
<term>Vulnerable Populations</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Betacoronavirus</term>
<term>Comorbidité</term>
<term>Enfant</term>
<term>Facteurs âges</term>
<term>Humains</term>
<term>Interactions médicamenteuses</term>
<term>Observance par le patient</term>
<term>Pandémies</term>
<term>Populations vulnérables</term>
<term>Post-cure</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Équipe soignante</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>France</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>OBJECTIVE</b>
</p>
<p>The lack of ressources and coordination to face the epidemic of coronavirus raises concerns for the health of patients with mental disorders in a country where we keep in memory the dramatic experience of famine in psychiatric hospitals during the Second World War. This article aims at proposing guidance to ensure mental health care during the SARS-CoV epidemy in France.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>METHODS</b>
</p>
<p>Authors performed a narrative review identifying relevant results in the scientific and medical literature and local initiatives in France.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>We identified four types of major vulnerabilities in patients suffering from mental disorders during this pandemic: (1) medical comorbidities that are more frequently found in patients suffering from mental disorders (cardiovascular and pulmonary pathologies, diabetes, obesity, etc.) which represent risk factors for severe infections with Covid-19; (2) age (the elderly constituting the population most vulnerable to coronavirus); (3) cognitive and behavioral troubles which can hamper compliance with confinement and hygiene measures and finally and (4) psychosocial vulnerability due to stigmatization and/or socio-economic difficulties. Furthermore, the mental health healthcare system is more vulnerable than other healthcare systems. Current government plans are poorly adapted to psychiatric establishments in a context of major shortage of organizational, material and human resources. In addition, a certain number of structural aspects make the psychiatric institution particularly vulnerable: many beds are closed, wards have a high density of patients, mental health community facilities are closed, medical teams are understaffed and poorly trained to face infectious diseases. We could also face major issues in referring patients with acute mental disorders to intensive care units. To maintain continuity of psychiatric care in this pandemic situation, several directions can be considered, in particular with the creation of Covid+ units. These units are under the dual supervision of a psychiatrist and of an internist/infectious disease specialist; all new entrants should be placed in quarantine for 14 days; the nurse staff should benefit from specific training, from daily medical check-ups and from close psychological support. Family visits would be prohibited and replaced by videoconference. At the end of hospitalization, in particular for the population of patients in compulsory ambulatory care situations, specific case-management should be organized with the possibility of home visits, in order to support them when they get back home and to help them to cope with the experience of confinement, which is at risk to induce recurrences of mental disorders. The total or partial closure of mental health community facilities is particularly disturbing for patients but a regular follow-up is possible with telemedicine and should include the monitoring of the suicide risk and psychoeducation strategies; developing support platforms could also be very helpful in this context. Private psychiatrists have also a crucial role of information with their patients on confinement and barrier measures, but also on measures to prevent the psychological risks inherent to confinement: maintenance of sleep regularity, physical exercise, social interactions, stress management and coping strategies, prevention of addictions, etc. They should also be trained to prevent, detect and treat early warning symptoms of post-traumatic stress disorder, because their prevalence was high in the regions of China most affected by the pandemic.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>DISCUSSION</b>
</p>
<p>French mental healthcare is now in a great and urgent need for reorganization and must also prepare in the coming days and weeks to face an epidemic of emotional disorders due to the containment of the general population.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32312567</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>07</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>07</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0013-7006</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>46</Volume>
<Issue>3S</Issue>
<PubDate>
<Year>2020</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>L'Encephale</Title>
<ISOAbbreviation>Encephale</ISOAbbreviation>
</Journal>
<ArticleTitle>[Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review].</ArticleTitle>
<Pagination>
<MedlinePgn>S3-S13</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0013-7006(20)30064-6</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.encep.2020.03.001</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The lack of ressources and coordination to face the epidemic of coronavirus raises concerns for the health of patients with mental disorders in a country where we keep in memory the dramatic experience of famine in psychiatric hospitals during the Second World War. This article aims at proposing guidance to ensure mental health care during the SARS-CoV epidemy in France.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Authors performed a narrative review identifying relevant results in the scientific and medical literature and local initiatives in France.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified four types of major vulnerabilities in patients suffering from mental disorders during this pandemic: (1) medical comorbidities that are more frequently found in patients suffering from mental disorders (cardiovascular and pulmonary pathologies, diabetes, obesity, etc.) which represent risk factors for severe infections with Covid-19; (2) age (the elderly constituting the population most vulnerable to coronavirus); (3) cognitive and behavioral troubles which can hamper compliance with confinement and hygiene measures and finally and (4) psychosocial vulnerability due to stigmatization and/or socio-economic difficulties. Furthermore, the mental health healthcare system is more vulnerable than other healthcare systems. Current government plans are poorly adapted to psychiatric establishments in a context of major shortage of organizational, material and human resources. In addition, a certain number of structural aspects make the psychiatric institution particularly vulnerable: many beds are closed, wards have a high density of patients, mental health community facilities are closed, medical teams are understaffed and poorly trained to face infectious diseases. We could also face major issues in referring patients with acute mental disorders to intensive care units. To maintain continuity of psychiatric care in this pandemic situation, several directions can be considered, in particular with the creation of Covid+ units. These units are under the dual supervision of a psychiatrist and of an internist/infectious disease specialist; all new entrants should be placed in quarantine for 14 days; the nurse staff should benefit from specific training, from daily medical check-ups and from close psychological support. Family visits would be prohibited and replaced by videoconference. At the end of hospitalization, in particular for the population of patients in compulsory ambulatory care situations, specific case-management should be organized with the possibility of home visits, in order to support them when they get back home and to help them to cope with the experience of confinement, which is at risk to induce recurrences of mental disorders. The total or partial closure of mental health community facilities is particularly disturbing for patients but a regular follow-up is possible with telemedicine and should include the monitoring of the suicide risk and psychoeducation strategies; developing support platforms could also be very helpful in this context. Private psychiatrists have also a crucial role of information with their patients on confinement and barrier measures, but also on measures to prevent the psychological risks inherent to confinement: maintenance of sleep regularity, physical exercise, social interactions, stress management and coping strategies, prevention of addictions, etc. They should also be trained to prevent, detect and treat early warning symptoms of post-traumatic stress disorder, because their prevalence was high in the regions of China most affected by the pandemic.</AbstractText>
<AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">French mental healthcare is now in a great and urgent need for reorganization and must also prepare in the coming days and weeks to face an epidemic of emotional disorders due to the containment of the general population.</AbstractText>
<CopyrightInformation>Copyright © 2020 L'Encéphale, Paris. Published by Elsevier Masson SAS. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chevance</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Université de Paris, CRESS, Inserm, INRA, 75004 Paris, France. Electronic address: astrid.chevance@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gourion</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>HEC Paris (Jouy-en-Josas), Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hoertel</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Centre ressource régional de psychiatrie du sujet âgé (CRRPSA), service de psychiatrie et d'addictologie de l'adulte et du sujet âgé, DMU psychiatrie et addictologie, Inserm U1266, institut de psychiatrie et neurosciences de Paris, centre université de Paris, AP-HP, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Llorca</LastName>
<ForeName>P-M</ForeName>
<Initials>PM</Initials>
<AffiliationInfo>
<Affiliation>Université Clermont-Auvergne, CHU de Clermont-Ferrand, Clermont-Ferrand, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thomas</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Laboratoire de sciences cognitives et sciences affectives (SCALab-PsyCHIC), université de Lille, CNRS UMR 9193, CHU de Lille, Lille, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bocher</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>CHU de Nantes, Nantes, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moro</LastName>
<ForeName>M-R</ForeName>
<Initials>MR</Initials>
<AffiliationInfo>
<Affiliation>Université de Paris, collège national des universitaires de psychiatrie (CNUP), Inserm, CESP, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Laprévote</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Pôle hospitalo-universitaire de psychiatrie d'adultes et d'addictologie du Grand-Nancy, centre psychothérapique de Nancy, Laxou, France; Faculté de médecine, université de Lorraine, Nancy, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Benyamina</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Département de psychiatrie et d'addictologie, hôpital Paul-Brousse, AP-HP, 94800 Villejuif, France; Unité psychiatrie-comorbidités-addictions-unité de recherche, PSYCOMADD université Paris Sud, université Paris Saclay, AP-HP, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fossati</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Service de psychiatrie adultes, Sorbonne université, groupe hospitalier Pitié-Salpêtrière, ICM, Inserm U1127, AP-HP, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Masson</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>SHU, GHU psychiatrie et neurosciences, Nightingale Hospitals-Paris, clinique du Château-de-Garches, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Leaune</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Centre hospitalier Le Vinatier, Bron, France; Université Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Leboyer</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Université Paris Est Créteil, Inserm, Fondation FondaMental, AP-HP, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gaillard</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Université de Paris, GHU psychiatrie et neurosciences, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>fre</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<VernacularTitle>Assurer les soins aux patients souffrant de troubles psychiques en France pendant l’épidémie à SARS-CoV-2.</VernacularTitle>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>04</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>France</Country>
<MedlineTA>Encephale</MedlineTA>
<NlmUniqueID>7505643</NlmUniqueID>
<ISSNLinking>0013-7006</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000359" MajorTopicYN="N">Aftercare</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003266" MajorTopicYN="N">Continuity of Patient Care</DescriptorName>
<QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004347" MajorTopicYN="N">Drug Interactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006757" MajorTopicYN="N">Hospital Units</DescriptorName>
<QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006778" MajorTopicYN="N">Hospitals, Psychiatric</DescriptorName>
<QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017053" MajorTopicYN="N">Infection Control</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008605" MajorTopicYN="N">Mental Health Services</DescriptorName>
<QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName>
<QualifierName UI="Q000600" MajorTopicYN="N">supply & distribution</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010348" MajorTopicYN="N">Patient Care Team</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010349" MajorTopicYN="N">Patient Compliance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011329" MajorTopicYN="N">Prisoners</DescriptorName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013313" MajorTopicYN="N">Stress Disorders, Post-Traumatic</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013315" MajorTopicYN="N">Stress, Psychological</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019966" MajorTopicYN="N">Substance-Related Disorders</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013405" MajorTopicYN="N">Suicide</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D035862" MajorTopicYN="N">Vulnerable Populations</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Coronavirus</Keyword>
<Keyword MajorTopicYN="N">Covid-19</Keyword>
<Keyword MajorTopicYN="N">Epidemy</Keyword>
<Keyword MajorTopicYN="N">France</Keyword>
<Keyword MajorTopicYN="N">Pandemy</Keyword>
<Keyword MajorTopicYN="N">Pandémie</Keyword>
<Keyword MajorTopicYN="N">Psychiatrie</Keyword>
<Keyword MajorTopicYN="N">Psychiatry</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="N">Santé mentale</Keyword>
<Keyword MajorTopicYN="N">Épidémie</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>03</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>03</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>4</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>7</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>4</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32312567</ArticleId>
<ArticleId IdType="pii">S0013-7006(20)30064-6</ArticleId>
<ArticleId IdType="doi">10.1016/j.encep.2020.03.001</ArticleId>
<ArticleId IdType="pmc">PMC7130411</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Auvergne (région administrative)</li>
<li>Auvergne-Rhône-Alpes</li>
<li>Grand Est</li>
<li>Hauts-de-France</li>
<li>Lorraine (région)</li>
<li>Nord-Pas-de-Calais</li>
<li>Pays de la Loire</li>
<li>Rhône-Alpes</li>
<li>Île-de-France</li>
</region>
<settlement>
<li>Clermont-Ferrand</li>
<li>Lille</li>
<li>Lyon</li>
<li>Nancy</li>
<li>Nantes</li>
<li>Paris</li>
</settlement>
</list>
<tree>
<country name="France">
<region name="Île-de-France">
<name sortKey="Chevance, A" sort="Chevance, A" uniqKey="Chevance A" first="A" last="Chevance">A. Chevance</name>
</region>
<name sortKey="Benyamina, A" sort="Benyamina, A" uniqKey="Benyamina A" first="A" last="Benyamina">A. Benyamina</name>
<name sortKey="Bocher, R" sort="Bocher, R" uniqKey="Bocher R" first="R" last="Bocher">R. Bocher</name>
<name sortKey="Fossati, P" sort="Fossati, P" uniqKey="Fossati P" first="P" last="Fossati">P. Fossati</name>
<name sortKey="Gaillard, R" sort="Gaillard, R" uniqKey="Gaillard R" first="R" last="Gaillard">R. Gaillard</name>
<name sortKey="Gourion, D" sort="Gourion, D" uniqKey="Gourion D" first="D" last="Gourion">D. Gourion</name>
<name sortKey="Hoertel, N" sort="Hoertel, N" uniqKey="Hoertel N" first="N" last="Hoertel">N. Hoertel</name>
<name sortKey="Laprevote, V" sort="Laprevote, V" uniqKey="Laprevote V" first="V" last="Laprévote">V. Laprévote</name>
<name sortKey="Leaune, E" sort="Leaune, E" uniqKey="Leaune E" first="E" last="Leaune">E. Leaune</name>
<name sortKey="Leboyer, M" sort="Leboyer, M" uniqKey="Leboyer M" first="M" last="Leboyer">M. Leboyer</name>
<name sortKey="Llorca, P M" sort="Llorca, P M" uniqKey="Llorca P" first="P-M" last="Llorca">P-M Llorca</name>
<name sortKey="Masson, M" sort="Masson, M" uniqKey="Masson M" first="M" last="Masson">M. Masson</name>
<name sortKey="Moro, M R" sort="Moro, M R" uniqKey="Moro M" first="M-R" last="Moro">M-R Moro</name>
<name sortKey="Thomas, P" sort="Thomas, P" uniqKey="Thomas P" first="P" last="Thomas">P. Thomas</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000180 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000180 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32312567
   |texte=   [Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32312567" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021